Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04753489
Status:
UNKNOWN
Last Update Posted:
2021-02-15
First Post:
2021-02-10
Brief Title:
Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 10 mg in Healthy Male Volunteers in Fasting Conditions
Sponsor:
Pharmtechnology LLC
Organization:
Pharmtechnology LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-13
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-10
First Submit QC Date:
February 10 2021
Study First Post Date:
2021-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-10
Last Update Post Date:
2021-02-15
Last Update Post Date Type:
ACTUAL